Would you like to contribute to this site?
Arthritis Menu
Submit an Article
Submit a Tip
Place your Ad
Add URL
Arthritis Questions?
Contact Us
Related Topics:
Rheumatoid Arthritis
Rheumatoid Arthritis Diagnosis
Rheumatoid Arthritis Disability
Rheumatoid Arthritis Knee
Rheumatoid Arthritis Nutrition
Rheumatoid Arthritis Prognosis
Rheumatoid Arthritis Test
Type Of Rheumatoid Arthritis
People With Rheumatoid Arthritis
Rheumatoid Arthiritis
Rheumatoid Arthritis Info
Cure For Rheumatoid Arthritis
Rheumetoid Arthritis
Other Channels:
|
 |
|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent Rheumatoid Arthritis Nutrition News:
|
|
|
01/10/2010-Genentech ( NYSE:DNA ) said late Saturday that the U.S. Food and Drug Administration has approved its new drug, Actemra, for the treatment of rheumatoid arthritis. Hal Barron, chief medical officer for Genentech and its parent company, the ...
Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with moderately to severely ...
MONDAY, Jan. 11 (HealthDay News) -- New research offers a caution to rheumatoid arthritis patients who take the drug rituximab (Rituxan): The flu vaccine is safe, but it's ineffective during the first six months following treatment with Rituxan. The ...
The U.S. Food and Drug Administration approved Actemra (tocilizumab) to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis. Washington ...
Editor's note: The Food and Drug Administration has approved Actemra for the treatment of rheumatoid arthritis (RA), Genentech, Inc. announced this week. There is no cure for the health condition though. We posted an article below for those who may ...
| |
| |
|
|
|
Additional Rheumatoid Arthritis Nutrition Resources:
|
|
|
|
|
|
|
|
|
Want your site featured on this page?
|
|
 |
|